Fig. 7.
Impact of exposure times on antichlamydial effect of compounds. (A) HeLa cells infected with C. trachomatis L2 EBs at a MOI of 0.2 were treated with 240 μM compound 1 or 480 μM compound 2 or 3 at different time points as described. (B) The inhibitory effect of compounds on the production of infectious progeny EBs at different time points was determined by counting recoverable IFUs in compound treated samples relative to untreated negative control at 36 h.